Oct 12 (Reuters) - RVL Pharmaceuticals PLC RVLP.O :
* RVL PHARMACEUTICALS PLC ANNOUNCES PREPACKAGED
REORGANIZATION OF
CERTAIN U.S. SUBSIDIARIES
* RVL PHARMACEUTICALS PLC: BUSINESS OPERATIONS AT U.S.
SUBSIDIARIES TO CONTINUE AS THEY PURSUE STRATEGIC PLAN
* RVL PHARMACEUTICALS PLC - RVLP ORDINARY SHARES EXPECTED TO
BE
CANCELLED
* RVL PHARMACEUTICALS PLC - SENIOR SECURED LENDER TO
EXCHANGE
OUTSTANDING DEBT INTO EQUITY OF REORGANIZED ENTITIES
* RVL PHARMACEUTICALS PLC - RVL'S PUBLIC EQUITY IS EXPECTED
TO BE
CANCELLED UPON COMPLETION OF ITS WIND-DOWN, ANTICIPATED TO BE
DURING 2024
* RVL PHARMACEUTICALS PLC - EXPECTED TO COMMENCE WIND-DOWN
OF ANY
REMAINING OPERATIONS OF COMPANY AND ITS SUBSIDIARIES, OTHER THAN
RVL SUBSIDIARIES
* RVL PHARMACEUTICALS - REORGANIZATION CONTEMPLATES THAT ALL
OF
RVL SUBSIDIARIES' VENDORS, SUPPLIERS, AND CUSTOMERS WILL BE
UNAFFECTED BY REORGANIZATION
* RVL PHARMACEUTICALS PLC - REORGANIZATION CONTEMPLATES THAT
ALL
RVL SUBSIDIARIES' VENDORS, SUPPLIERS, AND CUSTOMERS WILL BE
UNAFFECTED BY REORGANIZATION
Source text for Eikon: ID:nGNX1BrZst
Further company coverage: RVLP.O
((Reuters.Briefs@thomsonreuters.com;))